Key points are not available for this paper at this time.
Surface the urgent dilemma that healthcare delivery organizations (HDOs) face navigating the US Food and Drug Administration (FDA) final guidance on the use of clinical decision support (CDS) software.
Sendak et al. (Mon,) studied this question.